Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Haofang Biotech is a specialized manufacturer of high-end chemical reagents primarily used in the synthesis of peptides, proteins, and oligonucleotides. Founded in 2003 and headquartered in Shanghai, the company has established itself as a global leader in amide coupling reagents, protecting groups, and protein cross-linking agents. Its product portfolio is critical for the pharmaceutical industry, supporting the development and commercial production of complex drugs such as GLP-1 receptor agonists. The company operates large-scale manufacturing facilities and serves a diverse client base including major pharmaceutical firms, biotechnology companies, and contract research organizations. Haofang Biotech is publicly traded on the Shenzhen Stock Exchange and continues to expand its capabilities in life science research tools and specialty chemicals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Haofang Biotechnology.